Autoimmune Hepatitis. Evolving Concepts and Treatment Strategies

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 1995 Feb 1

PMID 7851212

Citations 30

Authors

A J Czaja

Affiliations

Soon will be listed here.

Citing Articles

Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure.

Fujiwara K, Yasui S, Yokosuka O Hepatol Int. 2015; 7(2):335-46.

PMID: 26201768 DOI: 10.1007/s12072-012-9402-3.

A case of primary biliary cirrhosis and autoimmune hepatitis overlap showing acute presentation and transient seropositivity for immunoglobulin G and anti-nuclear antibody.

Fujiwara K, Seza K, Fukuda Y, Nakano M, Yokosuka O Clin J Gastroenterol. 2015; 6(6):465-9.

PMID: 26182138 DOI: 10.1007/s12328-013-0423-9.

Chinese medicine bu xu hua yu recipe for the regulation of treg/th17 ratio imbalance in autoimmune hepatitis.

Wang L, Du H, Liu Y, Wang L, Ma X, Zhang W Evid Based Complement Alternat Med. 2015; 2015:461294.

PMID: 25977698 PMC: 4419233. DOI: 10.1155/2015/461294.

Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.

Yuksel M, Laukens D, Heindryckx F, Van Vlierberghe H, Geerts A, Wong F Int J Exp Pathol. 2014; 95(5):309-20.

PMID: 25112417 PMC: 4209923. DOI: 10.1111/iep.12090.

Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.

Zhang W, Zhao F, Chen J, Chen W PLoS One. 2014; 9(3):e92267.

PMID: 24651126 PMC: 3961308. DOI: 10.1371/journal.pone.0092267.

References

Stellon A, Keating J, Johnson P, McFarlane I, Williams R . Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology. 1988; 8(4):781-4. DOI: 10.1002/hep.1840080414. View

Hegarty J, Nouri Aria K, Portmann B, Eddleston A, Williams R . Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983; 3(5):685-9. DOI: 10.1002/hep.1840030510. View

Saracco G, Touscoz A, Durazzo M, Rosina F, Donegani E, Chiandussi L . Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis. J Hepatol. 1990; 11(3):339-43. DOI: 10.1016/0168-8278(90)90218-g. View

Si L, Whiteside T, Schade R, Van Thiel D . Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH). J Clin Immunol. 1983; 3(4):408-19. DOI: 10.1007/BF00915803. View

Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K . Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology. 1992; 16(2):300-5. DOI: 10.1002/hep.1840160204. View

Heuman D, Pandak W, Hylemon P, VLAHCEVIC Z . Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology. 1991; 14(5):920-6. DOI: 10.1002/hep.1840140527. View

Magrin S, Craxi A, Fabiano C, Fiorentino G, Almasio P, Palazzo U . Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol. 1991; 13(3):364-7. DOI: 10.1016/0168-8278(91)90082-m. View

Wee A, Ludwig J . Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?. Ann Intern Med. 1985; 102(5):581-7. DOI: 10.7326/0003-4819-102-5-581. View

Czaja A . Chronic active hepatitis: the challenge for a new nomenclature. Ann Intern Med. 1993; 119(6):510-7. DOI: 10.7326/0003-4819-119-6-199309150-00011. View

10.

Treichel U, Gerken G, Rossol S, ROTTHAUWE H, Meyer zum Buschenfelde K, Poralla T . Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol. 1993; 19(1):55-63. DOI: 10.1016/s0168-8278(05)80176-x. View

11.

Canafax D, Ascher N . Cyclosporine immunosuppression. Clin Pharm. 1983; 2(6):515-24. View

12.

Czaja A . Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis. Hepatology. 1990; 11(6):1044-9. DOI: 10.1002/hep.1840110621. View

13.

MIRACCO A, Iodice G, Peluso C, Quarentelli A, Selce P, Tedesco A . Arginine thiazolidinecarboxylate in the treatment of chronic active hepatitis: double-blind comparison with placebo. J Int Med Res. 1984; 12(1):35-9. DOI: 10.1177/030006058401200106. View

14.

HOMBERG J, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil S . Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology. 1987; 7(6):1333-9. DOI: 10.1002/hep.1840070626. View

15.

Tan E . Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989; 44:93-151. DOI: 10.1016/s0065-2776(08)60641-0. View

16.

Czaja A, CARPENTER H, Santrach P, Moore S . Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology. 1993; 18(4):816-22. DOI: 10.1002/hep.1840180411. View

17.

Amontree J, Stuart T, Bredfeldt J . Autoimmune chronic active hepatitis masquerading as acute hepatitis. J Clin Gastroenterol. 1989; 11(3):303-7. DOI: 10.1097/00004836-198906000-00012. View

18.

Maddrey W . Subdivisions of idiopathic autoimmune chronic active hepatitis. Hepatology. 1987; 7(6):1372-5. DOI: 10.1002/hep.1840070631. View

19.

Vergani D, Mieli-Vergani G . Type II autoimmune hepatitis. What is the role of the hepatitis C virus?. Gastroenterology. 1993; 104(6):1870-3. DOI: 10.1016/0016-5085(93)90673-z. View

20.

Stechemesser E, Klein R, Berg P . Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology. 1993; 18(1):1-9. View